RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $5.296B (100.0% shares, 0.0% debt)

Holdings (54)

ASND ASCENDIS PHARMA A/S 18.9%
Value $1.002B Shares 11,225,357 Est. Cost $79.32 Unrealized
LEGN LEGEND BIOTECH CORP 8.2%
Value $432M Shares 6,264,707 Est. Cost $58.19 Unrealized
PCVX VAXCYTE INC 7.4%
Value $394M Shares 7,891,254 Est. Cost $35.36 Unrealized +34.1%
DICE THERAPEUTICS INC 6.9%
Value $365M Shares 7,856,612 Est. Cost $31.90 Unrealized
89BIO INC 4.1%
Value $216M Shares 11,416,948 Est. Cost $16.58 Unrealized
BIIB BIOGEN INC 2.9%
Value $152M Shares 532,892 Est. Cost $216.32 Unrealized +37.7%
AEROVATE THERAPEUTICS INC 2.7%
Value $142M Shares 8,263,982 Est. Cost $22.83 Unrealized
VERONA PHARMA PLC 2.5%
Value $134M Shares 6,317,990 Est. Cost $7.68 Unrealized
CUREVAC N V 2.4%
Value $128M Shares 12,245,955 Est. Cost $6.97 Unrealized
TYRA TYRA BIOSCIENCES INC 2.3%
Value $123M Shares 7,236,454 Est. Cost $19.11 Unrealized -24.1%
NAMS NEWAMSTERDAM PHARMA COMPANY 2.0%
Value $107M Shares 9,000,000 Est. Cost $11.79 Unrealized +12.5%
CTKB CYTEK BIOSCIENCES INC 2.0%
Value $105M Shares 12,297,721 Est. Cost $20.70 Unrealized -56.7%
JANX JANUX THERAPEUTICS INC 1.9%
Value $103M Shares 8,670,644 Est. Cost $22.27 Unrealized -40.0%
GERN GERON CORP 1.9%
Value $101M Shares 31,544,806 Est. Cost $2.29 Unrealized +24.3%
INHIBRX INC 1.9%
Value $100M Shares 3,853,867 Est. Cost $24.64 Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 1.8%
Value $93.6M Shares 5,676,067 Est. Cost $23.94 Unrealized -24.6%
DAWN DAY ONE BIOPHARMACEUTICALS I 1.8%
Value $93.25M Shares 7,809,852 Est. Cost $17.63 Unrealized -25.9%
RXST RXSIGHT INC 1.7%
Value $87.92M Shares 3,052,796 Est. Cost $13.76 Unrealized +61.6%
COGT COGENT COMMUNICATIONS HLDGS 1.4%
Value $75.97M Shares 6,416,147 Est. Cost $13.15 Unrealized -12.8%
PEPG PEPGEN INC 1.4%
Value $72.7M Shares 8,131,952 Est. Cost $11.15 Unrealized +17.2%
AXSM AXSOME THERAPEUTICS INC 1.4%
Value $71.86M Shares 1,000,000 Est. Cost $73.77 Unrealized 0.0%
RNAM AVIDITY BIOSCIENCES INC 1.3%
Value $71.16M Shares 6,416,998 Est. Cost $16.99 Unrealized -26.2%
VOR BIOPHARMA INC 1.3%
Value $70.29M Shares 22,748,880 Est. Cost $24.47 Unrealized
GHRS GH RESEARCH PLC 1.3%
Value $66.29M Shares 5,587,333 Est. Cost $17.97 Unrealized -42.9%
WVE WAVE LIFE SCIENCES LTD 1.2%
Value $62.62M Shares 17,202,009 Est. Cost $8.85 Unrealized -54.4%
ACRV ACRIVON THERAPEUTICS INC 1.2%
Value $62.34M Shares 4,810,508 Est. Cost $12.69 Unrealized -4.7%
ICOSAVAX INC 1.1%
Value $59.22M Shares 5,963,565 Est. Cost $28.89 Unrealized
ITEOS THERAPEUTICS INC 1.1%
Value $58.48M Shares 4,417,259 Est. Cost $24.67 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 1.0%
Value $55.47M Shares 3,069,531 Est. Cost $18.41 Unrealized 0.0%
MLYS MINERALYS THERAPEUTICS INC 1.0%
Value $54.19M Shares 3,178,476 Est. Cost $16.83 Unrealized -11.2%
ALPINE IMMUNE SCIENCES INC 0.9%
Value $48.23M Shares 4,691,178 Est. Cost $7.23 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 0.9%
Value $47.77M Shares 2,007,946 Est. Cost $25.89 Unrealized -0.9%
ABOS ACUMEN PHARMACEUTICALS INC 0.9%
Value $47M Shares 9,770,773 Est. Cost $16.64 Unrealized -71.2%
ACRS ACLARIS THERAPEUTICS INC 0.9%
Value $45.61M Shares 4,398,453 Est. Cost $13.86 Unrealized -34.7%
IMMUNOGEN INC 0.8%
Value $43.97M Shares 2,329,958 Est. Cost $5.49 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 0.8%
Value $43.32M Shares 2,122,465 Est. Cost $20.34 Unrealized -0.6%
FULC FULCRUM THERAPEUTICS INC 0.7%
Value $38.31M Shares 11,609,704 Est. Cost $7.35 Unrealized -60.0%
CLYM ELIEM THERAPEUTICS INC 0.7%
Value $36.82M Shares 13,150,849 Est. Cost $20.66 Unrealized -85.3%
TNYA TENAYA THERAPEUTICS INC 0.7%
Value $35.62M Shares 6,067,483 Est. Cost $7.47 Unrealized -22.2%
ANTX AN2 THERAPEUTICS INC 0.6%
Value $32.07M Shares 3,773,517 Est. Cost $15.13 Unrealized -52.5%
PLRX PLIANT THERAPEUTICS INC 0.6%
Value $31.93M Shares 1,762,000 Est. Cost $28.47 Unrealized -16.9%
EYPT EYEPOINT PHARMACEUTICALS INC 0.6%
Value $29.32M Shares 3,370,506 Est. Cost $11.52 Unrealized -47.0%
SPRY ARS PHARMACEUTICALS INC 0.4%
Value $20.16M Shares 3,009,678 Est. Cost $6.49 Unrealized +2.3%
HOWL WEREWOLF THERAPEUTICS INC 0.4%
Value $18.74M Shares 6,144,881 Est. Cost $10.47 Unrealized -73.1%
DSGN DESIGN THERAPEUTICS INC 0.4%
Value $18.72M Shares 2,971,231 Est. Cost $27.75 Unrealized -77.9%
SLDB SOLID BIOSCIENCES INC 0.3%
Value $17.95M Shares 3,426,286 Est. Cost $6.55 Unrealized -14.1%
BDTX BLACK DIAMOND THERAPEUTICS I 0.3%
Value $17.81M Shares 3,525,754 Est. Cost $22.74 Unrealized -91.0%
NKTX NKARTA INC 0.3%
Value $17.09M Shares 7,805,129 Est. Cost $24.86 Unrealized -82.3%
CELC CELCUITY INC 0.3%
Value $15.37M Shares 1,400,001 Est. Cost $10.24 Unrealized +1.5%
IGM BIOSCIENCES INC 0.2%
Value $8.653M Shares 937,500 Est. Cost $9.23 Unrealized
CONNECT BIOPHARMA HLDGS LTD 0.1%
Value $7.9M Shares 6,991,003 Est. Cost $19.09 Unrealized
TALARIS THERAPEUTICS INC 0.1%
Value $7.093M Shares 2,333,175 Est. Cost $3.04 Unrealized
NANOSTRING TECHNOLOGIES 0.1%
Value $6.98M Shares 1,723,373 Est. Cost $10.06 Unrealized
NAMSW NEWAMSTERDAM PHARMA COMPANY 0.0%
Value $697K Shares 333,333 Est. Cost $0.87 Unrealized